NDAORALTABLET
Approved
Jun 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
11
Clinical Trials (5)
Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight
Started Nov 2008
13 enrolled
Advanced Cancer
Twenty-six Week Extension Trial of Org 50081 (Esmirtazapine) in Outpatients With Chronic Primary Insomnia (176003/P05721/MK-8265-007)
Started Oct 2008
184 enrolled
Sleep Initiation and Maintenance DisordersMental DisordersDyssomnias+2 more
A Long-Term Safety Study of Org 50081 (Esmirtazapine) in Elderly Outpatients With Chronic Primary Insomnia (176005/P05697/MK-8265-001)
Started Jan 2008
259 enrolled
Sleep Initiation and Maintenance Disorder; ElderlyMental DisorderDyssomnias+2 more
Efficacy and Safety Study of Org 50081 (Esmirtazapine) in Elderly Participants (P05709)
Started Nov 2007
538 enrolled
InsomniaSleep Initiation and Maintenance DisordersMental Disorders+2 more
A Six Week, Double-Blind Randomized, Efficacy and Safety, Sleep Lab Trial With Esmirtazapine (Org 50081) (P05707)
Started Jun 2007
419 enrolled
Insomnia